Urothelial carcinoma: the evolving landscape of immunotherapy for patients with advanced disease – Dove Medical Press
|
Urothelial carcinoma: the evolving landscape of immunotherapy for patients with advanced disease
Dove Medical Press Abstract: Urothelial carcinoma is the sixth most common malignancy in the US. While most patients present with non-muscle-invasive disease, many will develop recurrent disease including some progressing to muscle invasive metastatic cancer. Treatment … |
